Back to Search
STEVEN KNAUER, M.D.
M.D.
Anesthesiology Physician
NPI: 1376518191IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
MD2018-0026(NM)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Class of 1998
Research & Publications (20)
Melanoma-specific ferrocene esters of the fungal cytotoxin illudin M.
PMID 19606019·Anticancer Drugs·2009
8-other
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
PMID 19130609·Int J Cancer·2009
4-observational
Pt(II) complexes of a combretastatin A-4 analogous chalcone: effects of conjugation on cytotoxicity, tumor specificity, and long-term tumor growth suppression.
PMID 19102652·J Med Chem·2009
8-other
Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1.
PMID 19074427·J Biol Chem·2009
8-other
Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis.
PMID 17653085·Oncogene·2008
8-other
Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility.
PMID 17906697·Oncogene·2008
7-preclinical
Conjugates of the fungal cytotoxin illudin M with improved tumour specificity.
PMID 18715789·Bioorg Med Chem·2008
8-other
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
PMID 18593915·Cancer Res·2008
8-other
Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
PMID 17334981·J Pathol·2007
8-other
The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
PMID 17960333·Strahlenther Onkol·2007
4-observational
Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential.
PMID 17617794·Int J Cancer·2007
6-review
Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.
PMID 17616652·Cancer Res·2007
6-review
The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
PMID 17582222·Cell Cycle·2007
4-observational
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.
PMID 17330232·Int J Cancer·2007
8-other
Monoterpenes as drug shuttles: cytotoxic (6-aminomethylnicotinate)dichloridoplatinum(II) complexes with potential to overcome cisplatin resistance.
PMID 17328536·J Med Chem·2007
8-other
Nuclear export is essential for the tumor-promoting activity of survivin.
PMID 17099069·FASEB J·2007
8-other
Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
PMID 16179940·Cell Death Differ·2006
8-other
The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.
PMID 17099693·EMBO Rep·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2430 W PIERCE ST
CARLSBAD, NM 88220 - Phone
- (575) 887-4100
Quick Facts
- NPI
- 1376518191
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile